Concomitant Medications. A. No acute use of antibiotics (oral, inhaled or IV) or acute use of systemic corticosteroids for respiratory tract symptoms from the Screening Visit to Visit 1. B. More than 70% compliance with submission of daily ePRO questionnaires in the up to 13 days prior to Visit 1. C. Among the daily ePRO questionnaires submitted in the up to 13 days prior to Visit 1, at least 70% adherence with taking ETI and as applicable, hypertonic saline and/or dornase alfa, as reported from Screening to Visit 1.
Appears in 3 contracts
Sources: Protocol Agreement, Protocol Agreement, Protocol Agreement